NCT05877859
- Conditions
- Breast Cancer Invasive, Breast Cancer Stage II, Breast Cancer Stage III, +8 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
Clinical trial condition
Breast Cancer Triple Negative
Explore clinical trials studying Breast Cancer Triple Negative. Study availability and eligibility vary by location and protocol.
4 public trials
3 recruiting studies
Breast Cancer Triple Negative trial results
NCT07188246
- Conditions
- Breast Cancer, Breast Cancer Invasive, Breast Cancer Stage II, +9 more
- Locations
-
- St. Joseph's Health Care London London, Ontario, Canada
- St. Joseph's Health Care London London, Ontario, Canada
Recruiting
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
NCT06532812
- Conditions
- Breast Cancer, Breast Cancer Metastatic, Breast Cancer Triple Negative, +8 more
- Locations
-
- District One Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
NCT05128734
- Conditions
- Breast Cancer Triple Negative, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada